Triple
T5981259
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Elan Pharmaceuticals |
E133121
|
entity |
| Predicate | hadSubsidiary |
P9212
|
FINISHED |
| Object |
Elan Drug Technologies
Elan Drug Technologies was the drug delivery and development division of Elan Pharmaceuticals, specializing in advanced formulation and delivery technologies for pharmaceutical products.
|
E133121
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Elan Drug Technologies | Statement: [Elan Pharmaceuticals, hadSubsidiary, Elan Drug Technologies]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Elan Drug Technologies Context triple: [Elan Pharmaceuticals, hadSubsidiary, Elan Drug Technologies]
-
A.
Elan Pharmaceuticals
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
-
B.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
C.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
D.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
-
E.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Elan Drug Technologies Triple: [Elan Pharmaceuticals, hadSubsidiary, Elan Drug Technologies]
Generated description
Elan Drug Technologies was the drug delivery and development division of Elan Pharmaceuticals, specializing in advanced formulation and delivery technologies for pharmaceutical products.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Elan Drug Technologies Target entity description: Elan Drug Technologies was the drug delivery and development division of Elan Pharmaceuticals, specializing in advanced formulation and delivery technologies for pharmaceutical products.
-
A.
Elan Pharmaceuticals
chosen
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
-
B.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
C.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
D.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
-
E.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0086f45e8819098f73dd16d45ec9d |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c04a67c3248190ba35a7121eb49672 |
completed | March 22, 2026, 8 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c0e42174a88190b8b40cbc7815911f |
completed | March 23, 2026, 6:56 a.m. |
| NEDg | Description generation | batch_69c0f602b79881909a6d971972f760b1 |
completed | March 23, 2026, 8:12 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c0f6a75b908190b35d13b9593cf21f |
completed | March 23, 2026, 8:15 a.m. |
Created at: March 22, 2026, 4:04 p.m.